Patients with atrophic gastritis with severe intestinal metaplasia need to take at least 3 months to get relief, and endoscopic surgery is needed if necessary.
Atrophic gastritis with severe intestinal metaplasia, refers to the patient in the gastric mucosa atrophy, gland reduction based on intestinal epithelial metaplasia (that is, the gastric mucosal epithelial cells by intestinal mucosal epithelial cells to replace a pathological phenomenon), can appear nausea, vomiting, acid reflux, heartburn, stomach pain, stomach distension and other symptoms.
Atrophic gastritis with severe intestinal metaplasia can be treated with proton pump inhibitors such as esomeprazole and omeprazole, thus relieving the symptoms of acid reflux, heartburn and heartburn sensation; gastric mucous membrane protectors such as aluminum thioglycollate and bismuth potassium citrate, thus improving the symptoms of stomach pain and nausea; and microbial agents such as Lactobacillus and Bacillus subtilis, which can promote gastrointestinal digestion and absorption of food and improve the symptoms of gastric distention and belching.
Patients with atrophic gastritis with severe intestinal metaplasia have a longer treatment course, some patients need to be treated for 3 months, sometimes it can be extended to half a year, and endoscopic surgery is needed if necessary.
Patients with atrophic gastritis with severe intestinal metaplasia are advised to seek timely medical attention for a clear diagnosis and targeted treatment. In addition, all of the above drugs should be taken under the guidance of a doctor and should not be used without authorization.